Prognostic value of the TCGA molecular classification in uterine carcinosarcoma-Reference-Cited by-同舟云学术

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma

Published:2021-10-11 Issue: Volume: Page:
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:Int J Gynecol Obstet

Author:

Travaglino Antonio¹²,Raffone Antonio³⁴,Raimondo Diego⁴,Arciuolo Damiano¹,Angelico Giuseppe¹,Valente Michele¹,Scaglione Giulia¹,D’alessandris Nicoletta¹,Casadio Paolo⁴,Inzani Frediano¹,Mollo Antonio⁵,Santoro Angela¹,Seracchioli Renato⁴,Franco Zannoni Gian¹⁶

Affiliation:

1. Gynecopathology and Breast Pathology Unit Department of Woman’s Health Science Agostino Gemelli University Polyclinic Rome Italy

2. Pathology Unit Department of Advanced Biomedical Sciences School of Medicine University of Naples Federico II Naples Italy

3. Gynecology and Obstetrics Unit Department of Neuroscience, Reproductive Sciences and Dentistry School of Medicine University of Naples Federico II Naples Italy

4. Division of Gynecology and Human Reproduction Physiopathology Department of Medical and Surgical Sciences (DIMEC) IRCCS Azienda Ospedaliero‐Univeristaria di Bologna S Orsola HospitalUniversity of Bologna Bologna Italy

5. Gynecology and Obstetrics Unit Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana" University of Salerno Baronissi Italy

6. Catholic University of Sacred Heart Rome Italy

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijgo.13937

Reference48 articles.

1. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity

2. Update on treatment of uterine sarcoma

3. Abu‐RustumNR YasharCM BradleyK et al.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) – Uterine neoplasms. Version 1.2021 – October 20 2020.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma;Gynecologic Oncology Reports;2024-10

2. New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles;Pathology International;2024-08-22

3. An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature;Gynecologic Oncology Reports;2024-08

4. Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications;Cancers;2024-07-04

5. Non-Metastatic Uterine Carcinosarcoma: A Tailored Approach or One Size Fits All?;Radiation;2024-06-05